Bactobio
PrivateLast Round
Convertible Debt
Dec 5, 2022
Total Funding Raised
$14.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Bactobio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Convertible Debt round in December 2022.
Bactobio is a biotechnology company that uses genomics, machine learning, and bioengineering to culture previously unculturable microbes to discover novel antibiotics and sustainable plant protection solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bactobio Comparables
Compare Bactobio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hexagon Bio | 83% | |
| NovoBiotic Pharmaceuticals | 76% | |
| Biosortia Microbiomics | 73% |
For institutional investors. Book with your work email.
Bactobio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Dec 5, 2022 | ||||
| Grant | Oct 25, 2022 | ||||
| Grant | Jun 9, 2022 | ||||
| Grant | Apr 1, 2022 | ||||
| Grant | Oct 2, 2021 | ||||
Seed | Oct 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bactobio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Granatus Ventures | Convertible Debt |
| Pioneer Fund | Convertible Debt |
| UK Agri-Tech Centre | Seed |
| Entangle S.A. | Convertible Debt |
| Meltwind Advisory | Seed |
| Bridford Group | Convertible Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 118% MoM, from 2.6K to 5.6K.
- Jan 1, 2026
First product commercialization planned for H1 2026.
For institutional investors. Book with your work email.
Bactobio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bactobio's valuation, stock price, and market status.
Is Bactobio a public or private company?
Bactobio is a private company.
What is the current stock price of Bactobio?
Bactobio is a private company, so its shares have no public market price. Caplight tracks Bactobio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bactobio worth (valuation)?
Valuation information for Bactobio is not publicly available.
Can I buy Bactobio stock?
Bactobio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bactobio's last funding round?
Bactobio's most recent funding round was Convertible Debt on December 5, 2022.
Who are the main investors in Bactobio?
Key investors in Bactobio include Bridford Group.
Will Bactobio IPO soon?
No public IPO plans have been announced for Bactobio.
How can I track Bactobio secondary market activity?
Caplight tracks bids, offers, and trades in Bactobio's shares on secondary markets.